Citadel Group discloses 1.93% stake in Avadel Pharmaceuticals
PositiveFinancial Markets

Citadel Group has announced a 1.93% stake in Avadel Pharmaceuticals, signaling confidence in the company's potential. This investment is significant as it reflects Citadel's strategic interest in the pharmaceutical sector, particularly in companies that are innovating in drug development. Such moves can boost investor confidence and potentially lead to increased market activity around Avadel.
— Curated by the World Pulse Now AI Editorial System






